New Delhi, April 4 (IANS) In a ray of hope for millions suffering from cancer, President Droupadi Murmu on Thursday unveiled the country’s first indigenously-made and affordable gene therapy for the deadly disease.
Launching the gene therapy treatment called “CAR-T cell therapy” at IIT Bombay, President Murmu said that it will be successful in giving new lives to countless patients.
This cell therapy has been available in developed nations for some time but is extremely costly and beyond the reach of most patients globally, including in India.
President Murmu said it is an example of the ‘Make in India’ initiative which is a shining example of the ‘Atmanirbhar Bharat’.
The ‘CAR-T cell therapy’ has been developed via collaboration between the IIT Bombay and Tata Memorial Hospital, in association with industry partner ImmunoACT, which is “a praiseworthy example of academia-industry partnership.”
President Murmu said that with the knowledge base and skills of the faculty and students of IIT Bombay and other similar institutions, India “would benefit greatly from the technological revolution underway.”
CAR-T cell therapy or chimeric antigen receptor T-cell therapy is a form of immunotherapy and gene therapy. It requires complex genetic engineering to modify the patient’s immune cells, especially T cells, and make them fight cancer.
“The development of this therapy in India over the past decade and its approval in October 2023 speaks volumes about the skills of Indian scientists and physicians,” said President Murmu.
Cancer has claimed a large number of lives around the world. In India, 14.6 lakh people succumbed to it in 2022, and the number is likely to rise to 15.7 lakh by 2025.
“The therapy being launched today is a major step — in fact, a new milestone in the journey of healthcare innovation in India. It puts us on the global map of advanced medical care as well as on the elite list of countries, which have access to this most innovative technology platform,” President Murmu emphasised.
–IANS
na/DAN
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
